Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 255 | 298 | 109 | 0 | 15 |
| Operating Income | -255 | -298 | -109 | N/A | -15 |
| Other Income | 1,333 | 419 | 21 | 0 | 0 |
| Pre-tax Income | 1,077 | 121 | -88 | 0 | -15 |
| Net Income Continuous | 1,077 | 121 | -88 | N/A | -15 |
| Net Income | $1,077 | $121 | $-88 | $N/A | $-15 |
| EPS Basic Total Ops | 36.04 | 0.00 | -12.01 | N/A | 0.00 |
| EPS Basic Continuous Ops | 180.03 | 20.17 | -14.68 | N/A | -2.94 |
| EPS Diluted Total Ops | 36.04 | 0.00 | -12.01 | N/A | 0.00 |
| EPS Diluted Continuous Ops | 180.03 | 20.17 | -14.68 | N/A | -2.94 |
| EBITDA(a) | $-255 | $-298 | $-109 | $N/A | $-15 |